IntroductionMonocytes are produced in the bone marrow; they circulate in blood for 1 to 3 days before entering tissues or undergo apoptosis if they do not encounter specific survival signals. [1][2][3] The mechanisms regulating monocyte apoptosis are not fully understood. It is known, however, that lipopolysaccharide (LPS), granulocytemacrophage colony stimulating factor (GM-CSF), macrophage CSF (M-CSF), TNF-␣, and interleukin-1 (IL-1) all inhibit monocyte apoptosis and induce prolonged monocyte survival. [3][4][5] Monocytes play an important role in initiating activation of the innate immune system, for example, phagocytosis further activates monocytes to secrete proinflammatory cytokines and chemokines in inflamed tissues. 6 Monocytes can differentiate into either macrophages, 7 which display enhanced ability to phagocytose, or dendritic cells (DCs), 8 which function as antigen-presenting cells that play a central role in activating the adaptive immune system. These cells provide a first-line host defense against viral and bacterial infection.B-lymphocyte stimulator (BLyS) is a member of the TNF family (also named BAFF, zTNF4, THANK, and Tall-1), which is expressed as a full-length 285-amino acid transmembrane molecule, and cleaved from cells as a 152-amino acid soluble ligand following processing by a furinlike protease. 9,10 Soluble BLyS exists as a trimer or oligomer and is thought to be the primary effector of in vivo function. However, cell-associated BLyS also induced proliferation of anti-IgM-stimulated B lymphocytes, 10 and more recently, T cells were shown to respond only to immobilized BLyS. 11,12 BLyS is produced by myeloid lineage cells, malignant B cells, activated T cells, and bone marrow stromal cells. [13][14][15][16][17] Monocyte stimulation with IFN-␥, TNF-␣, or IL-10 increases BLyS production. 14 Bacterial components such as LPS and peptidoglycan can also up-regulate BLyS secretion by macrophages, dendritic cells, and monocytes. 14,18 BLyS has 3 receptors: BCMA (B-cell maturation antigen), TACI (transmembrane activator and CAML interactor), and BAFF-R (BAFF receptor). [19][20][21][22] These receptors belong to the TNF receptor superfamily; all receptors possess an extracellular domain containing multiple cysteine-rich domains (CRDs) and intracellular sequences containing TNF receptor-associated protein (TRAF) binding sites. These receptors are primarily expressed in B-lineage cells. BCMA is exclusively expressed in B cells. However, a subset of T cells has also been shown to express TACI and BAFF-R. 11,12,23 Because of the expression pattern of BLyS receptors, most studies to date have focused on the effects of BLyS on adaptive immune cells, and these studies show that BLyS costimulates B-cell proliferation and induces cell survival 18,24 and can also function as a T-cell costimulatory molecule. 11,12,23 Whether BLyS has functional effects on other cell lineages has not been reported.BLyS transgenic mice developed a syndrome with similarities to systemic lupus erythematosus (SLE) in humans...